Fidelity International’s Immunomedics Inc IMMU Stock Holding History

Fidelity International’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-945,928	Closed	-$80.4M	–	1132
2020 Q3	$80.4M	Buy	945,928 +945,509	+225,658%	+$47.8M	0.1%	218
2020 Q2	$15K	Sell	419 -247,631	-100%	-$7.24M	﹤0.01%	722
2020 Q1	$3.34M	Buy	248,050 +14,652	+6%	+$247K	0.01%	542
2019 Q4	$4.94M	Sell	233,398 -63,970	-22%	-$1.13M	0.01%	573
2019 Q3	$3.94M	Buy	297,368 +212,911	+252%	+$3.13M	0.01%	571
2019 Q2	$1.17M	Sell	84,457 -16,362	-16%	-$246K	﹤0.01%	630
2019 Q1	$1.94M	Buy	+100,819	New	+$1.62M	﹤0.01%	570

Fidelity International's IMMU Position: Q4 2020 in Review

Fidelity International sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 945,928 shares — an estimated $80.4M sold.

Fidelity International first reported a position in IMMU in Q1 2019 and held it in 7 quarters. The position peaked at $80.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Fidelity International reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Fidelity International sold 945,928 Immunomedics Inc shares in Q4 2020, an estimated $80.4M.
Fidelity International first reported a position in Immunomedics Inc in Q1 2019 and held it in 7 quarters.
Fidelity International's Immunomedics Inc position peaked at $80.4M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Fidelity International's 13F filing for Q4 2020, filed 8 Feb 2021.